Publications by authors named "Ganzenko V"
[The expanded immunization program: results, prospects, new problems].
Zh Mikrobiol Epidemiol Immunobiol
March 1997
Article Synopsis
- The study focused on the meningococcal polyvalent ABC-vaccine to determine the best vaccination doses for children aged 0.5-15 years.
- Researchers measured specific bactericidal antibodies before and 30 days after immunization to assess the vaccine's effectiveness.
- The findings established optimal vaccine doses based on age groups: 80 µg for 0.5-2 years, 100 µg for 3-7 years, 120 µg for 8-11 years, and 160 µg for 12-15 years, achieving a strong immune response in 95-100% of vaccinated children.
The investigation was carried out to study the safety and reactogenicity of meningococcal chemical polyvalent (ABC) vaccine with the aim of finding the optimum vaccination doses of this vaccine for the immunization of children of different age groups. The investigation, carried out in accordance with the methodological principles of a strictly controlled epidemiological field trial, showed the preparation to be safe, nonreactogenic and to produce no pronounced sensitizing effect.
View Article and Find Full Text PDF